Alpenglow Biosciences and Molecular Instruments announce a new partnership to enable full-volume 3D RNA imaging in intact tissues, and celebrate with the launch of the 3D Imaging World Cup 2025.

Alpenglow Biosciences and ZEISS announce a new partnership to co-develop an inverted light-sheet microscope and AI-driven bioinformatics pipeline designed to advance clinical 3D pathology.

Alpenglow Biosciences will highlight 3D pathology innovations for skin disease at SID 2025 as a Gold Sponsor, with a featured symposium on alopecia led by Prof. Maria Hordinsky and Dr. Nicholas Reder.

Join Alpenglow Biosciences at AACR 2025 for a special dinner event featuring Dr. Sammy Ferri-Borgogno on the role of 2D and 3D spatial biology in decoding endometrial cancers.

Alpenglow Biosciences adds industry veterans Blandine Merino and Mike Rice to its Advisory Board to support growth in digital pathology, 3D imaging, and precision medicine.

Alpenglow Biosciences launches LUMI, a new user interface designed to simplify light-sheet microscopy and 3D imaging workflows, debuting at ABRF 2025.

Alpenglow Biosciences and Incyte Corporation will present groundbreaking 3D imaging research at SID 2025, showcasing how 3D imaging reveals neuroimmune dynamics in atopic dermatitis treated with ruxolitinib cream. Using Alpenglow’s Aurora 3Di light-sheet microscopy, the study provides unprecedented insights into nerve volume, immune cell distribution, and epidermal remodeling.